NON-ALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NON-ALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NON-ALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NON-ALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Herbal capsule could shrink fatty liver in new trial
Disease control Not yet recruitingThis study tests whether a Chinese herbal capsule called Linzhi Jianghuang Fufang Huoxue Anshen (LJF) can safely reduce liver fat in people with non-alcoholic fatty liver disease. About 180 adults aged 18 to 65 with high liver fat will take the capsule or a placebo for 24 weeks. …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Hong Kong Baptist University • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New combo pill aims to tackle fatty liver, obesity, and diabetes at once
Disease control Not yet recruitingThis early study tests whether adding an experimental drug (CS0159) to a standard diabetes medication (semaglutide) can help people with fatty liver disease, obesity, and type 2 diabetes lose weight and improve their health. About 30 adults will take the combination or a placebo …
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
AI diet coach takes on fatty liver: 216-Person trial launches
Disease control Not yet recruitingThis study tests whether an artificial intelligence (AI) program that gives personalized diet and exercise advice can help people with non-alcoholic fatty liver disease (NAFLD) reduce liver fat more than standard lifestyle counseling. About 216 adults with NAFLD and overweight wi…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill XTYW007 enters human testing for fatty liver
Disease control Not yet recruitingThis early-stage trial is testing a new drug called XTYW007 in healthy volunteers and people with high LDL cholesterol. The main goal is to check the drug's safety and how the body processes it, not yet to see if it treats non-alcoholic fatty liver disease (NAFLD). The study will…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: EARLY_PHASE1 • Sponsor: Xi'an Xintong Pharmaceutical Research Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a diabetes drug help teens with fatty liver?
Disease control Not yet recruitingThis study tests whether empagliflozin, a drug used for diabetes, can help teens with non-alcoholic fatty liver disease (NAFLD) and obesity. Forty participants will take either the drug or a placebo for several weeks. The main goal is to see if the drug reduces liver fat measured…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Herbal brew takes on fatty liver: new trial launches
Disease control Not yet recruitingThis study tests whether a traditional Chinese herbal formula called Longqi Jiangzhi decoction can help treat non-alcoholic fatty liver disease in adults. Eighty participants will take either the herbal medicine or a placebo daily for eight weeks. Researchers will measure liver f…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Shanghai Municipal Hospital of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Blood fats and nanoparticles may reveal hidden clues in autoimmune liver disease
Knowledge-focused Not yet recruitingThis study looks at two types of liver disease — autoimmune hepatitis and non-alcoholic fatty liver disease — to see if fats in blood cells and tiny particles called extracellular vesicles differ between them. Researchers will collect blood samples from 24 adults and analyze thes…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Blood markers may reveal hidden liver damage in fatty liver patients
Knowledge-focused Not yet recruitingThis study looks at whether certain blood test results (hs-CRP, triglycerides, and glucose) can help identify liver scarring in people with non-alcoholic fatty liver disease (NAFLD). Researchers will observe 96 adults who have NAFLD and check their blood markers alongside liver s…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Scientists probe whether cutting insulin levels can curb liver fat
Knowledge-focused Not yet recruitingThis study looks at how lowering insulin levels changes the way the liver makes sugar and fat. Researchers will give 36 overweight or obese adults with insulin resistance and fatty liver disease two different insulin infusions—one that keeps insulin high and one that lowers it by…
Matched conditions: NON-ALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE1 • Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC